Clinical Trials Browser

Phase 4 × Rituximab × 90 days × Clear all

NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Phase 4 Recruiting

LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

NCT06031233 2026-03-30

MINUTE

Phase 4 Recruiting

Neoplasms